SE175504C1 - - Google Patents

Info

Publication number
SE175504C1
SE175504C1 SE175504DA SE175504C1 SE 175504 C1 SE175504 C1 SE 175504C1 SE 175504D A SE175504D A SE 175504DA SE 175504 C1 SE175504 C1 SE 175504C1
Authority
SE
Sweden
Prior art keywords
phosphorus oxychloride
tri
process according
carbon atoms
phosphate
Prior art date
Application number
Other languages
English (en)
Swedish (sv)
Publication date
Publication of SE175504C1 publication Critical patent/SE175504C1/sv

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE175504D SE175504C1 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE175504T

Publications (1)

Publication Number Publication Date
SE175504C1 true SE175504C1 (cs) 1961-01-01

Family

ID=41964667

Family Applications (1)

Application Number Title Priority Date Filing Date
SE175504D SE175504C1 (cs)

Country Status (1)

Country Link
SE (1) SE175504C1 (cs)

Similar Documents

Publication Publication Date Title
EP1339717B1 (de) Neue carbamat-substituierte pyrazolopyridinderivate
EP1339716B1 (de) lactam-substituierte pyrazolopyridinderivate
US3818035A (en) 2{8 (2-ALKYLBENZO{8 b{9 {11 FURAN-3 yl)METHYL{9 -{66 {11 IMIDAZOLINE
JPS60226882A (ja) 新規ピリミドピリミジン誘導体
SK46599A3 (en) Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems
JPS61257951A (ja) 新規なアリ−ル誘導体
WO2003086407A1 (de) Verwendung von stimulatoren der löslichen guanylatcyclase zur behandlung von glaukom
US10323044B2 (en) Crystal of imidazo-oxazine, pharmaceutical composition containing said crystal, and method for producing said crystal
CN111410661A (zh) 帽依赖性内切核酸酶抑制剂及其用途
JPS6284052A (ja) 〔（２，３，９，９ａ‐テトラヒドロ―３‐オキソ‐９ａ‐置換‐１Ｈ‐フルオレン―７‐イル）オキシ〕エタンイミドアミド類、〔（２，３，９，９ａ‐テトラヒドロ‐３‐オキソ‐９ａ‐置換‐１Ｈ‐フルオレン‐７‐イル）オキシ〕エタンイミド酸ヒドラジド類その誘導体および塩
DE69914614T2 (de) Ungesättigte hydroximsäurederivate als parp inhibitoren
SK2722002A3 (en) Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia
EP1560818A1 (en) Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
US20040063948A1 (en) Crystalline fluoroquinolone arginine salt form
CN111166745A (zh) 含消旋氧吡格雷或其盐的组合物及应用
JPS62190184A (ja) ８α−アクリルアミノエルゴリン、その製造方法および該化合物を含有する医薬組成物
CN113387909B (zh) 2,3-环氧丁二酰衍生物的医药用途
SE175504C1 (cs)
EP0000693B1 (de) Aminophenoxymethyl-2-morpholinderivate, ihre Herstellung und sie enthaltende Arzneimittel
HU196069B (en) Process for production of 8-/dihydropiridil-carbamoiloxi-methil/-ergolines and medical compounds containing these compositions
JPS61158980A (ja) ８α‐アシルアミノエルゴリン類、その製法および医薬組成物
WO2006088080A1 (ja) シクロヘプタ［ｂ］ピリジン－３－カルボニルグアニジン誘導体およびそれを含有する医薬品
US3073740A (en) Method of reducing cholesterol levels with tri- (dialkylaminoalkyl) phosphates
JPS6230779A (ja) 新規化合物，その製法及びそれを含む医薬組成物
EP3868768A1 (en) Pharmaceutical crystal of contezolid acefosamil, preparation method therefor, and uses thereof